Scandion Oncology AS (OSTO:SCOL) Preferred Dividends : kr0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Scandion Oncology AS Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Scandion Oncology AS's preferred dividends for the three months ended in Sep. 2024 was kr0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Sep. 2024 was kr0.00 Mil.

Scandion Oncology AS Preferred Dividends Historical Data

The historical data trend for Scandion Oncology AS's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scandion Oncology AS Preferred Dividends Chart

Scandion Oncology AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Preferred Dividends

Get a 7-Day Free Trial

Scandion Oncology AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Preferred Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Scandion Oncology AS Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Scandion Oncology AS (OSTO:SCOL) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

Scandion Oncology AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scandion Oncology AS (OSTO:SCOL) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

8VY:Germany

Address

Fruebjergvej 3, Symbion, Copenhagen, DNK, 2100

Website

https://www.scandiononcology.com

Scandion Oncology AS is a clinical-stage biotechnology company developing first-in-class medicines aimed at treating cancer that is resistant to current treatment options. Cancer Drug Resistance Company discovers and develops first-in-class medicines aimed at treating cancer that is resistant to current treatment options.

Scandion Oncology AS Headlines

No Headlines